The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

11 articles for A Chugh


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
AEBI
Advinus Therapeutics
Design and synthesis of novel, potent and selective hypoxanthine analogs as adenosine AEBI
Advinus Therapeutics
Discovery of pyrazole carboxylic acids as potent inhibitors of rat long chain L-2-hydroxy acid oxidase.EBI
Advinus Therapeutics
Discovery of a potent and selective small molecule hGPR91 antagonist.EBI
Advinus Therapeutics
Potent and Selective Inhibitors of Long Chain l-2-Hydroxy Acid Oxidase Reduced Blood Pressure in DOCA Salt-Treated Rats.EBI
TBA
Synthesis and optimization of novel and selective muscarinic M(3) receptor antagonists.EBI
Ranbaxy Research Laboratories
Discovery of conformationally rigid 3-azabicyclo[3.1.0]hexane-derived dipeptidyl peptidase-IV inhibitors.EBI
Ranbaxy Research Laboratories
Discovery of liver-directed glucokinase activator having anti-hyperglycemic effect without hypoglycemia.EBI
Advinus Therapeutics
Design, synthesis and activity of novel derivatives of oxybutynin and tolterodine.EBI
Ranbaxy Research Laboratories
Discovery of Potent and Selective AEBI
Advinus Therapeutics
Design and synthesis of novel xanthine derivatives as potent and selective AEBI
Advinus Therapeutics